Literature DB >> 1429602

An amino acid substitution (Gly853-->Glu) in the collagen alpha 1(II) chain produces hypochondrogenesis.

R Bogaert1, G E Tiller, M A Weis, H E Gruber, D L Rimoin, D H Cohn, D R Eyre.   

Abstract

The spondyloepiphyseal dysplasia subclassification of bone dysplasias includes achondrogenesis, hypochondrogenesis, and spondyloepiphyseal dysplasia congenita. The phenotypic expression of these disorders ranges from mild to perinatal lethal forms. We report the detection and partial characterization of a defect in type II collagen in a perinatal lethal form of hypochondrogenesis. Electrophoresis in sodium dodecyl sulfate-polyacrylamide of CB peptides (where CB represents cyanogen bromide) from type II collagen of the diseased cartilage showed a doublet band for peptide alpha 1(II)CB10 and evidence for post-translational overmodification of the major peptides (CB8, CB10, and CB11) seen as a retarded electrophoretic mobility. Peptide CB10 was digested by endoproteinase Asp-N; and on reverse-phase high pressure liquid chromatography, fragments of abnormal mobility were noted. Sequence analysis of a unique peptide D12 revealed a single amino acid substitution (Gly-->Glu) at position 853 of the triple helical domain. This was confirmed by sequence analysis of amplified COL2A1 cDNA, which revealed a single nucleotide substitution (GGA-->GAA) in 5 of 10 clones. Electron micrographs of the diseased cartilage showed a sparse extracellular matrix and chondrocytes containing dilated rough endoplasmic reticulum, which suggested impaired assembly and secretion of the mutant protein. This case further documents the molecular basis of the spondyloepiphyseal dysplasia spectrum of chondrodysplasias as mutations in COL2A1.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1429602

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

Review 1.  A bit of give and take: the relationship between the extracellular matrix and the developing chondrocyte.

Authors:  Danielle J Behonick; Zena Werb
Journal:  Mech Dev       Date:  2003-11       Impact factor: 1.882

2.  Report of five novel and one recurrent COL2A1 mutations with analysis of genotype-phenotype correlation in patients with a lethal type II collagen disorder.

Authors:  G R Mortier; M Weis; L Nuytinck; L M King; D J Wilkin; A De Paepe; R S Lachman; D L Rimoin; D R Eyre; D H Cohn
Journal:  J Med Genet       Date:  2000-04       Impact factor: 6.318

Review 3.  Genetic aspects of familial osteoarthritis.

Authors:  S A Jimenez; R M Dharmavaram
Journal:  Ann Rheum Dis       Date:  1994-12       Impact factor: 19.103

Review 4.  Clinical--molecular correlations in the skeletal dysplasias.

Authors:  D L Rimoin; D H Cohn; D Eyre
Journal:  Pediatr Radiol       Date:  1994

Review 5.  The type II collagenopathies: a spectrum of chondrodysplasias.

Authors:  J Spranger; A Winterpacht; B Zabel
Journal:  Eur J Pediatr       Date:  1994-02       Impact factor: 3.183

Review 6.  Genetic analysis of skeletal dysplasia: recent advances and perspectives in the post-genome-sequence era.

Authors:  Shiro Ikegawa
Journal:  J Hum Genet       Date:  2006-05-03       Impact factor: 3.172

Review 7.  Disorders of the growth plate.

Authors:  Chanika Phornphutkul; Philip A Gruppuso
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2009-12       Impact factor: 3.243

8.  Expression, in cartilage, of a 7-amino-acid deletion in type II collagen from two unrelated individuals with Kniest dysplasia.

Authors:  R Bogaert; D Wilkin; W R Wilcox; R Lachman; D Rimoin; D H Cohn; D R Eyre
Journal:  Am J Hum Genet       Date:  1994-12       Impact factor: 11.025

9.  Localization of the expression of type I, II and III collagen genes in human normal and hypochondrogenesis cartilage canals.

Authors:  D Le Guellec; F Mallein-Gerin; I Treilleux; J Bonaventure; P Peysson; D Herbage
Journal:  Histochem J       Date:  1994-09

10.  An RNA-splicing mutation (G+5IVS20) in the type II collagen gene (COL2A1) in a family with spondyloepiphyseal dysplasia congenita.

Authors:  G E Tiller; M A Weis; P A Polumbo; H E Gruber; D L Rimoin; D H Cohn; D R Eyre
Journal:  Am J Hum Genet       Date:  1995-02       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.